Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
OKYO
#6044
OKYO Pharma Limited Ordinary Shares
1.7
1
0.00%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
0.00%
Aylık değişim
-23.32%
6 aylık değişim
-24.67%
Yıllık değişim
+44.92%
Önceki kapanış
1.7
1
Open
1.7
1
Bid
Ask
Low
1.7
1
High
1.7
1
Hacim
2
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
OKYO
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.37 B
25.55 M
33.84 M
37.61 M
—
Valuation ratios
Enterprise value
—
—
48.91 M
43.17 M
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-1.26
2.56
10.9
1.28
—
Return on equity %
-1.84
-6.48
-2.86
-0.85
—
Return on invested capital %
—
—
—
—
—
Gross margin %
—
—
—
100
—
Operating margin %
—
—
—
-38.54 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
85.88 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
3.17
0.72
0.21
0.4
—
Inventory turnover
—
—
—
—
—
Asset turnover
0
0
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
Haberler
Piper Sandler, OKYO Pharma hissesine Ağırlıklı Al önerisi verdi
Piper Sandler initiates OKYO Pharma stock with Overweight rating
OKYO Pharma hisseleri 20 milyon dolarlık halka arz duyurusuyla sert düştü
OKYO Pharma stock tumbles on $20 million public offering announcement
OKYO Pharma 20 milyon dolarlık adi hisse senedi halka arzını duyurdu
OKYO Pharma announces $20 million public offering of ordinary shares
OKYO Pharma ATM hisse senedi teklifini satış aracısı olarak Leerink Partners’a devretti
OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent
OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program
OKYO Pharma, urcosimod NCP çalışma sonuçlarını ASCRS toplantısında sunacak
OKYO Pharma to present urcosimod NCP study results at ASCRS meeting
H.C. Wainwright, OKYO Pharma hissesi için Al tavsiyesini 7 dolar hedef fiyatla yineledi